Education
About Us
Working with TipRanks
Follow Us
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171
Ct041 Autologous Car T-Cell Injection, Physician's Choice（Paclitaxel Or Irinotecan Or Apatinib Or Anti-Pd-1 Antibody）
Pancreatic Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase I/II
Active Not Recruiting
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Sep 24, 2020
―
Ct041
Pancreatic Cancer, Gastric Cancer
Phase I/II
Active Not Recruiting
Claudin18.2 CAR-T (CT041) in Patients with Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
May 19, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does CARsgen Therapeutics Holdings Ltd. (2171) have in its pipeline
2171 is currently developing the following drugs: Ct041 Autologous Car T-Cell Injection, Physician's Choice（Paclitaxel Or Irinotecan Or Apatinib Or Anti-Pd-1 Antibody）, Ct041. These drug candidates are in various stages of clinical development as the company works toward FDA approval.